CoChat

Vascular Oxidative Stress: The Common Link in Hypertensive and Diabetic Vascular Disease

Open access
Cohen, Richard A, Tong, XiaoYong · 2010 · Journal of Cardiovascular Pharmacology
Cited by 125

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Vascular disease in hypertension and diabetes is associated with increased oxidants. The oxidants arise from NADPH oxidase, xanthine oxidase, and mitochondria. Superoxide anion and hydrogen peroxide are produced by both leukocytes and vascular cells. Nitric oxide is produced in excess by inducible nitric oxide synthase, and the potent oxidant, peroxynitrite, is formed from superoxide and nitric oxide. The damage to proteins caused by oxidants is selective, affecting specific oxidant-sensitive amino acid residues. With some important vascular proteins, for example, endothelial nitric oxide synthase, prostacycline synthase, and superoxide dismutase, oxidation of a single susceptible amino acid inactivates the enzyme. The beneficial effects of antioxidants, at least in animal models of hypertension and diabetes, can in part be ascribed to protection of these and other proteins. Mutant proteins lacking their reactive constituent can recapitulate some disease phenotypes suggesting a pathogenic role of the oxidation. Thus, many of the shared functional abnormalities of hypertensive and diabetic blood vessels may be caused by oxidants. Although studies using antioxidants have failed in patients, the successful treatment of vascular disease with HMG-CoA reductase inhibitors, thromboxane A2 antagonists, and polyphenols may depend on their anti-inflammatory effects and ability to decrease production of damaging oxidants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/fjc.0b013e3181d89670

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 79

  1. Contreras, 2000, J Hum Hypertens, 14, S26, 10.1038/sj.jhh.1000983 · DOI
  2. Savoia, 2006, Curr Diab Rep, 6, 274, 10.1007/s11892-006-0060-5 · DOI
  3. Adachi, 2005, Drug Discov Today, 2, 39, 10.1016/j.ddmec.2005.05.022 · DOI
  4. Adachi, 2004, J Biol Chem, 279, 29857, 10.1074/jbc.M313320200 · DOI · Paper page
  5. Clavreul, 2006, FASEB J, 20, 518, 10.1096/fj.05-4875fje · DOI · Paper page
  6. Adachi, 2004, Nat Med, 10, 1200, 10.1038/nm1119 · DOI · Paper page
  7. Ying, 2007, Arterioscler Thromb Vasc Biol, 27, 783, 10.1161/01.ATV.0000258413.72747.23 · DOI · Paper page
  8. Ellmark, 2005, Cardiovasc Res, 65, 495, 10.1016/j.cardiores.2004.10.026 · DOI · Paper page
  9. Meng, 2008, Cardiovasc Res, 80, 299, 10.1093/cvr/cvn173 · DOI · Paper page
  10. Touyz, 2004, Histochem Cell Biol, 122, 339, 10.1007/s00418-004-0696-7 · DOI · Paper page
  11. Touyz, 2003, Curr Opin Nephrol Hypertens, 12, 165, 10.1097/00041552-200303000-00007 · DOI
  12. Schiffrin, 2004, Am J Physiol Heart Circ Physiol, 287, H435, 10.1152/ajpheart.00262.2004 · DOI · Paper page
  13. Lassegue, 2003, Am J Physiol Regul Integr Comp Physiol, 285, R277, 10.1152/ajpregu.00758.2002 · DOI · Paper page
  14. Pagano, 1995, Am J Physiol, 268, H2274
  15. Wang, 1998, Circ Res, 82, 810, 10.1161/01.RES.82.7.810 · DOI · Paper page
  16. Wang, 1999, Hypertension, 33, 1225, 10.1161/01.HYP.33.5.1225 · DOI · Paper page
  17. Seshiah, 2002, Circ Res, 91, 406, 10.1161/01.RES.0000033523.08033.16 · DOI · Paper page
  18. Rajagopalan, 1996, J Clin Invest, 97, 1916, 10.1172/JCI118623 · DOI · Paper page
  19. Privratsky, 2003, Hypertension, 42, 206, 10.1161/01.HYP.0000082814.62655.85 · DOI · Paper page
  20. Ghiadoni, 2003, Hypertension, 41, 1281, 10.1161/01.HYP.0000070956.57418.22 · DOI · Paper page
  21. Wang, 2001, Circ Res, 88, 947, 10.1161/hh0901.089987 · DOI · Paper page
  22. Jung, 2004, Circulation, 109, 1795, 10.1161/01.CIR.0000124223.00113.A4 · DOI · Paper page
  23. Zhou, 2006, Hypertension, 47, 81, 10.1161/01.HYP.0000197182.65554.c7 · DOI
  24. Haurani, 2007, Cardiovasc Res, 75, 679, 10.1016/j.cardiores.2007.06.016 · DOI · Paper page
  25. Landmesser, 2002, Hypertension, 40, 511, 10.1161/01.HYP.0000032100.23772.98 · DOI · Paper page
  26. Williams, 1998, Circulation, 97, 1695, 10.1161/01.CIR.97.17.1695 · DOI · Paper page
  27. Rask-Madsen, 2007, Nat Clin Pract Endocrinol Metab, 3, 46, 10.1038/ncpendmet0366 · DOI · Paper page
  28. Quagliaro, 2005, Atherosclerosis, 183, 259, 10.1016/j.atherosclerosis.2005.03.015 · DOI · Paper page
  29. Liu, 2007, Free Radic Biol Med, 42, 852, 10.1016/j.freeradbiomed.2006.12.025 · DOI
  30. Guzik, 2002, Circulation, 105, 1656, 10.1161/01.CIR.0000012748.58444.08 · DOI · Paper page
  31. Lopez-Lopez, 2008, Am J Physiol Lung Cell Mol Physiol, 295, L727, 10.1152/ajplung.90354.2008 · DOI
  32. Ulker, 2004, Diabetes Obes Metab, 6, 442, 10.1111/j.1462-8902.2004.00443.x · DOI
  33. Vecchione, 2006, Circ Res, 98, 218, 10.1161/01.RES.0000200440.18768.30 · DOI
  34. Wei, 2007, Hypertension, 50, 384, 10.1161/HYPERTENSIONAHA.107.089284 · DOI · Paper page
  35. Molnar, 2005, Circ Res, 96, 1178, 10.1161/01.RES.0000168634.74330.ed · DOI · Paper page
  36. Matsumoto, 2003, Free Radic Res, 37, 767, 10.1080/1071576031000107344 · DOI · Paper page
  37. Cohen, 1993, Circulation, 87, V67
  38. Yang, 2002, Br J Pharmacol, 136, 104, 10.1038/sj.bjp.0704669 · DOI · Paper page
  39. Yang, 2003, Hypertension, 41, 143, 10.1161/01.HYP.0000047651.45322.16 · DOI · Paper page
  40. Yang, 2004, Fundam Clin Pharmacol, 18, 321, 10.1111/j.1472-8206.2004.00247.x · DOI
  41. Kanie, 2000, General Pharmacology: The Vascular System, 35, 311, 10.1016/S0306-3623(02)00115-5 · DOI
  42. Luscher, 1986, Hypertension, 8, 344, 10.1161/01.HYP.8.4.344 · DOI · Paper page
  43. Luscher, 1988, Hypertension, 11, 573, 10.1161/01.HYP.11.6.573 · DOI
  44. Diederich, 1990, Am J Physiol, 258, H445
  45. Bayat, 2008, Arterioscler Thromb Vasc Biol, 28, 127, 10.1161/ATVBAHA.107.150250 · DOI
  46. Zuccollo, 2005, Circulation, 112, 3001, 10.1161/CIRCULATIONAHA.105.581892 · DOI
  47. Xu, 2006, Diabetes, 55, 110, 10.2337/diabetes.55.01.06.db05-0831 · DOI · Paper page
  48. Wassmann, 2004, Hypertension, 44, 381, 10.1161/01.HYP.0000142232.29764.a7 · DOI · Paper page
  49. Redon, 2003, Hypertension, 41, 1096, 10.1161/01.HYP.0000068370.21009.38 · DOI · Paper page
  50. Tanito, 2004, Antioxid Redox Signal, 6, 89, 10.1089/152308604771978381 · DOI · Paper page
  51. Tagami, 1992, Metabolism, 41, 1053, 10.1016/0026-0495(92)90285-I · DOI
  52. Scheede-Bergdahl, 2005, Diabetes, 54, 3089, 10.2337/diabetes.54.11.3089 · DOI
  53. Zou, 1999, Am J Pathol, 154, 1359, 10.1016/S0002-9440(10)65390-4 · DOI · Paper page
  54. Schmidt, 2003, J Biol Chem, 278, 12813, 10.1074/jbc.M208080200 · DOI · Paper page
  55. Zou, 2002, Diabetes, 51, 198, 10.2337/diabetes.51.1.198 · DOI · Paper page
  56. Guo, 2003, Am J Physiol Heart Circ Physiol, 285, H1396, 10.1152/ajpheart.00096.2003 · DOI · Paper page
  57. Rosenthal, 2009, Journal of Biological Inorganic Chemistry, 14, 979, 10.1007/s00775-009-0550-4 · DOI
  58. Ying, 2008, Free Radic Biol Med, 45, 756, 10.1016/j.freeradbiomed.2008.05.029 · DOI
  59. Adachi, 2002, Circ Res, 90, 1114, 10.1161/01.RES.0000019757.57344.D5 · DOI · Paper page
  60. Beswick, 2001, Hypertension, 37, 781, 10.1161/01.HYP.37.2.781 · DOI · Paper page
  61. Hoffmann, 2008, Hypertension, 51, 1058, 10.1161/HYPERTENSIONAHA.107.107219 · DOI
  62. Jagadeesha, 2005, Am J Physiol Heart Circ Physiol, 289, H1047, 10.1152/ajpheart.01071.2004 · DOI
  63. Trujillo, 2008, Am J Physiol Renal Physiol, 295, F1574, 10.1152/ajprenal.90385.2008 · DOI
  64. DeRubertis, 2004, Diabetes, 53, 762, 10.2337/diabetes.53.3.762 · DOI · Paper page
  65. Ting, 1996, J Clin Invest, 97, 22, 10.1172/JCI118394 · DOI · Paper page
  66. Ting, 1996, Circulation, 94, I
  67. Plotnick, 1997, JAMA, 278, 1682, 10.1001/jama.1997.03550200058032 · DOI · Paper page
  68. Farmer, 2003, Am J Cardiol, 92, 3, 10.1016/S0002-9149(03)00503-4 · DOI
  69. Keli, 1996, Arch Intern Med, 154, 637, 10.1001/archinte.1996.00440060059007 · DOI · Paper page
  70. Leng, 1997, Vascular Medicine, 2, 279, 10.1177/1358863X9700200401 · DOI
  71. de Aguiar, 2006, Diabetes Care, 29, 1083, 10.2337/dc05-2146 · DOI · Paper page
  72. Rueckschloss, 2001, Circulation, 104, 1767, 10.1161/hc4001.097056 · DOI · Paper page
  73. Sumi, 2001, Atherosclerosis, 155, 347, 10.1016/S0021-9150(00)00597-9 · DOI
  74. Wagner, 2002, Arterioscler Thromb Vasc Biol, 20, 61, 10.1161/01.ATV.20.1.61 · DOI · Paper page
  75. Virdis, 2009, Hypertension, 53, 1008, 10.1161/HYPERTENSIONAHA.109.132258 · DOI
  76. Virdis, 2009, Hypertension, 53, 1008, 10.1161/HYPERTENSIONAHA.109.132258 · DOI
  77. Cayatte, 2000, Arterioscler Thromb Vasc Biol, 20, 1724, 10.1161/01.ATV.20.7.1724 · DOI · Paper page
  78. Zang, 2006, Diabetes, 55, 2180, 10.2337/db05-1188 · DOI · Paper page
  79. Cayatte, 2001, Arterioscler Thromb Vasc Biol, 21, 1577, 10.1161/hq1001.096723 · DOI · Paper page

Cited by

See all 125

Metadata

Authors
Cohen, R. A., & Tong, X.
Venue
Journal of Cardiovascular Pharmacology
Published
2010-04
Volume
55
Issue
4
Pages
308-316
ISSN
0160-2446 (ISSN-L)
OpenAlex
W2005457857
Cited by
125
References
23
FWCI
8.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vascular Oxidative Stress: The Common Link in Hypertensive and Diabetic Vascular Disease. https://app.cochat.ai/papers/10.1097/fjc.0b013e3181d89670
The paper
Cohen, R. A., & Tong, X. (2010). Vascular Oxidative Stress: The Common Link in Hypertensive and Diabetic Vascular Disease. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0b013e3181d89670

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.